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Patient satisfaction is an important aspect of dialysis care,
only recently evaluated in clinical studies. We developed a
tool to assess peritoneal dialysis (PD) customer satisfaction,
and sought to evaluate and validate the Customer
Satisfaction Questionnaire (CSQ), quantifying PD patient
satisfaction. The CSQ included questions regarding
administrative issues, Delivery Service, PD Training, Handling
Requests, and transportation. The study was performed using
interviews in all Hungarian Fresenius Medical Care dialysis
centers offering PD. CSQ results were compared with
psychosocial measures to identify if patient satisfaction was
associated with perception of social support and illness
burden, or depression. We assessed CSQ internal consistency
and validity. Factor analysis explored potential underlying
dimensions of the CSQ. One hundred and thirty-three
patients treated with PD for end-stage renal disease for more
than 3 months were interviewed. The CSQ had high internal
consistency. There was high patient satisfaction with
customer service. PD patient satisfaction scores correlated
with quality of life (QOL) and social support measures, but
not with medical or demographic factors, or depressive
affect. The CSQ is a reliable tool to assess PD customer
satisfaction. PD patient satisfaction is associated with
perception of QOL. Efforts to improve customer satisfaction
may improve PD patients’ quantity as well as QOL.
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Health-care quality and its improvements have become
increasingly important in medicine,1,2 including end-stage
renal disease (ESRD) care.3–5 Quality improvement pertains
to both the quality of dialysis treatment and its related
products and services.
Hard outcomes in ESRD patients treated with hemo-
dialysis (HD), such as mortality, are associated with psycho-
social variables such as depression, social support, or
patients’ perception of their illness,6–10 as well as affected
by age, diabetes mellitus, and other medical conditions.
Owing to the chronicity of ESRD, dialysis patients can spend
years of treatment in centers with extensive interaction with
dialysis staff.11 Patient satisfaction with care and caregivers is
an important aspect of dialysis treatment, which has only
been recently evaluated.9,12–14 Previous findings suggested
patient satisfaction with care is associated with perception
of quality of life (QOL) and burden of illness, as well as
improved intermediate outcomes, in ESRD HD patients.7,9,11
Although there is interest in patient satisfaction with
medical care and caregivers, relatively few data exist regarding
peritoneal dialysis (PD) patients. Wuerth et al.13 surveyed
elements of patient satisfaction in a PD unit. The Choice for
Healthy Outcomes in Caring for ESRD (CHOICE) study14
compared aspects of patient satisfaction in HD and PD
patients. Few data exist regarding relationships between
patient satisfaction, psychologic factors, and clinical charac-
teristics of PD patients. To investigate PD patient satisfaction,
Fresenius Medical Care (FME), a global dialysis product and
services provider, developed a Customer Satisfaction Ques-
tionnaire (CSQ). The primary study aim was to evaluate
and validate the CSQ as a standard tool for periodic
measurement of PD patient satisfaction. Secondary aims
addressed associations between patient satisfaction with
medical personnel and their (1) levels of depressive affect
and perception of social support and QOL, and (2) medical
and demographic parameters. We hypothesized that greater
patient satisfaction with medical care would be associated
with less depression and with higher levels of QOL and social
support.
RESULTS
One hundred and thirty-eight patients treated with PD for
more than 3 months were considered eligible. Five patients
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refused participation. One patient was too tired to complete
the entire interview, but his data were included in analyses.
Mean patient age was 56.7713.1 years (Table 1). Fifty-eight
(43.6%) were female and 31 (23.3%) had diabetes. Hemo-
globin (Hb) and serum albumin concentration (Salb) are
given in Table 2; 80.2% were treated with erythropoietin
(Table 2). Mean Karnofsky score was 78.8712.3 (Table 1).
Patients had had renal replacement therapy for 2.672.9
years and were on PD for a median of 1.42 years. PD was the
first choice of renal replacement therapy for 63.2% of
patients; 7.5% were treated with automated PD, and 64.3%
had not had peritonitis. Socioeconomic and psychologic data
are given in Table 2.
High mean scores for the Total Patient Satisfaction Score
(TPSS) and the CSQ were achieved (Table 2, Figure 1). Mean
TPSS was 16579.8 (range 97–170). Mean PD Patient
Satisfaction Score (PDPSS) was 200712.4 of a maximum
217 (range 151–217).
Patients with diabetes mellitus were on renal replacement
therapy for a shorter duration than those without diabetes
mellitus (1.871.2 vs 2.973.1 years, Po0.004), had lower Hb
(10.971.1 vs 11.471.6 g/dl, Po0.05), and higher Satis-
faction with Life Scale Scores (SWLS) (28.375.8 vs 25.27
7.0, Po0.02). Younger patients had higher Beck Depression
Inventory (BDI) scores (7.574.1 vs 5.373.3, P¼ 0.002), and
lower SWLS (24.777.1 vs 29.175.0, P¼ 0.0002). There were
no differences in mean PDPSS or CSQ subset scores between
older and younger patients, between patients with and
without diabetes mellitus, or between men and women.
Patient age correlated with lower Karnofsky scores (r¼
0.21, P¼ 0.017), and higher TPSS (r¼ 0.19, P¼ 0.027) and
SWL scores (r¼ 0.4, P¼ 0.0001), but not with illness
effects (Illness Effects Questionnaire (IEQ)), BDI, social
support (Multidimensional Scale of Perceived Social Support
(MPSS)), or PDPSS, or CSQ subset scores. PDPSS scores
correlated with all the CSQ subset scores (Table 3). In
addition, PDPSS scores correlated with TPSS, SWLS, and
MPSS scores (Table 3, Figure 2). Customer service scores
correlated with TPSS (r¼ 0.36, Po0.0001), and MPSS scores
(r¼ 0.23, P¼ 0.008). The correlation of CSS and SWLS
approached statistical significance (r¼ 0.18, P¼ 0.052)
(Figure 2). Delivery and PD Training scores did not correlate
with psychologic variables, but Handling Request scores
correlated with TPSS scores (r¼ 0.33, P¼ 0.0001), SWLS
(r¼ 0.24, P¼ 0.007), and MPSS scores (r¼ 0.19, P¼ 0.03)
(Figure 2). There was no correlation of PDPSS with Hb,
albumin or dialysis dose levels. TPSS scores correlated with
PDPSS, CSS, and Handling Requests scores, but not with
Delivery Service or PD Training scores (Figure 2).
As in HD studies, BDI scores correlated with several
psychosocial variables (TPSS, IEQ, SWL, and MPSS scores),
but not with laboratory parameters. There was no correlation
of depressive affect assessed by the BDI with the PDPSS
or any of its subscale scores. IEQ scores correlated with
TPSS, BDI, SWLS, and MPSS. As in HD studies, SWL corre-
lated with BDI, IEQ, and MPSS scores. In addition, SWLS
correlated with TPSS scores (r¼ 0.32, P¼ 0.0003), PDPSS,
and HR scores (r¼ 0.24, P¼ 0.007). The correlation of SWLS
and CSS approached significance (r¼ 0.18, P¼ 0.052).
All psychosocial questionnaires (MPSS, SWLS, TPSS, IEQ,
and BDI) had high internal consistency. Cronbach coefficient
alpha for MPSS was 0.88, for SWLS 0.82, TPSS 0.91, IEQ
0.85, and 0.79 for BDI. A coefficient of 0.81 was obtained for
the overall PDPSS, well above the accepted limit of 0.70
(Figure 3), indicating high internal consistency. The internal
Table 1 | Patient demographics and characteristics
Survey first
interview
Retest second
interview
N 133 60
Age (years) 56.7713.1 55.6713.0
465 years 29.3% 23.3%
Females 43.6% 38.3%
Time on PD (years) 2.672.9 2.571.7
PD as first RRT 63.2% 61.7%
APD 7.5% 6.7%
Diabetes 23.3% 26.7%
Functional status
(Karnofsky)
78.8712.3 79.8712.2
APD, automated peritoneal dialysis; PD, peritoneal dialysis; RRT, renal replacement
therapy.
Table 2 | Selected laboratory, socioeconomic, and psychologic
variables
Mean (Salb) 3.774.4 g/dl
Mean Hb 11.371.5 g/dl
Treated with erythropoietin 80.2%
Employed 12.8%
Secondary or higher education 68.4%
Mean BDI score 9.576.4
Mean IEQ score 45.8725.0
Mean SWLS score 25.976.8
Mean MPSS 25.373.4
Mean TTPSS 16579.8 (range 97–170)
Mean PDPSS 200712.4 (range 151–217)
Mean CSS 77.476.0 (range 50–84)
BDI, Beck Depression Inventory; CSS, Customer Satisfaction Score; Hb, hemoglobin;
IEQ, Illness Effects Questionnaire; MPSS, Multidimensional Scale of Perceived Social
Support; PDPSS, Peritoneal Dialysis Patient Satisfaction Score; SWLS, Satisfaction
with Life Scale; TPSS, Total Patient Satisfaction Score.
9.5 ± 6.4 
165 ± 9.8
200 ± 12.4 
59.0 ± 5.4
34.7 ± 0.9 
28.8 ± 5.0
77.4 ± 6.0 
25.3 ± 3.4
25.9 ± 6.9 
45.8 ± 25.0 
0 20 40 60 80 100 120 140 160 180 200 220
BDI
IEQ
TPSS
SWLS
MPSS
Customer service
Delivery service
PD training
Handling requests
PDPSS
Mean score ( ± s.d.)
Figure 1 | Mean scores of the individual questionnaires.
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consistency of the four separate PDPSS domains was
acceptable (Figure 3).
The Cronbach coefficient alpha of the revised CSQ was
0.91, higher than the value of the original PDSS used for first
interviews. Eight factors were extracted with eigenvalues 41,
accounting for 73% of the total variance in the data. Nineteen
of the 31 items had higher factor loadings in three different
factors, clearly forming groups according to the original
questionnaire’s sections. Thus, the factors ‘Satisfaction with
Customer Service’ (seven of 12 items in this section had
higher loading in this factor), ‘PD Training’ (five of five
items) and ‘Delivery Service’ (four of five items) were
identified. Six of nine items in the remaining ‘Handling
Requests’ section of the questionnaire had higher loadings
in three other factors, where no other item had higher
loading.
To assess the CSQ test–retest reliability, 60 of the 133
patients were randomly selected for a second interview
several months later. The mean time between the two inter-
views was 205.678.4 days. There were no differences
regarding the demographic data of the population compared
with the parent population (Table 1). The test–retest relia-
bility showed a significant correlation (r¼ 0.41, P¼ 0.0016)
between scores at the first and second interviews (mean
199.5715.8 vs 198.6713.7, NS).
DISCUSSION
This study shows a valid and reliable CSQ was developed for
use in ESRD PD outpatients. The Questionnaire subcate-
gories correlated highly with the total scale score, and the
total score correlated with a Patient Satisfaction scale
previously used in ESRD HD patients,9 suggesting the
composite score is a good overall measure of patient satis-
faction with the multiple processes that occur in PD care. The
subscale domains, however, are distinct and different, and
do reflect different aspects of care and are differentially
associated with the total score. Customer Service and Hand-
ling Requests scores are closely linked to the total PDPSS,
whereas perception of Delivery Service and PD Training are
less associated with the composite score. If a provider wishes
to increase total PD patient satisfaction, initiatives directed
towards improving specific aspects of care might be more
Table 3 | Correlations of total PDPSS and subscale scores with selected medical, and psychologic variables
Total PD patient satisfaction score PDSS subscales
Customer Service Delivery Service PD Training Handling Requests
r P-value r P-value r P-value r P-value r P-value
Age 0.17 0.063 0.14 0.11 0.11 0.22 0.13 0.13 0.07 0.42
Hemoglobin (g/dl) 0.069 0.45 0.05 0.54 0.10 0.28 0.005 0.96 0.10 0.24
Salb (g/dl) 0.59 0.52 0.09 0.32 0.08 0.37 0.13 0.13 0.01 0.89
Karnofsky score 0.13 0.16 0.10 0.25 0.10 0.24 0.07 0.40 0.07 0.46
SWLS 0.26 0.0037 0.18 0.052 0.16 0.08 0.09 0.30 0.24 0.007
MPSS 0.19 0.03 0.23 0.008 0.01 0.90 0.09 0.32 0.19 0.03
IEQ 0.36 o0.0001 0.05 0.62 0.02 0.86 0.34 0.72 0.11 0.28
BDI 0.08 0.43 0.05 0.63 0.05 0.59 0.05 0.62 0.11 0.27
TPSS 0.36 o0.0001 0.36 o0.0001 0.03 0.72 0.13 0.12 0.33 0.0001
Total PD Patient
Satisfaction Score
— — 0.79 o0.0001 0.59 o0.0001 0.37 o0.0001 0.81 o0.0001
BDI, Beck Depression Inventory; IEQ, Illness Effects Questionnaire; MPSS, Multidimensional Scale of Perceived Social Support; PD, peritoneal dialysis; PDPSS, Peritoneal Dialysis
Patient Satisfaction Score; Salb, serum albumin concentration; SWLS, Satisfaction with Life Scale; TPSS, Total Patient Satisfaction Score.
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Figure 2. | Validity of the CSQ.
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Figure 3 | Internal consistency of the overall CSQ and the four
separate domains.
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efficient. Alternatively, in an individual patient, and within
units, attention to specific subscales can help identify initia-
tives to improve patient care or be used for quality
improvement.
PD Patient Satisfaction correlated with TPSS and SWLS,
as well as perception of social support. There was no
correlation of psychosocial variables and Hb or Salb. There
was little indication of correlation of PD patient satisfaction
indices with either age or duration of renal replacement
therapy. Interestingly, there was no correlation of PD
patient satisfaction measured with the CSQ with the level
of depressive affect. However, total PDPSS correlated
with satisfaction with life and perception of social support,
indicating that PD patient satisfaction is a part of the
patients’ assessment of QOL, and that patient satisfaction
with staff functions as an important part of the patient
social support system. The findings regarding correlations of
patient satisfaction indices and perception of social support
in this study are similar to those reported in US HD
patients.9
In addition, PDPSS were not associated with levels of Salb
or Hb, or dose of dialysis, suggesting patient satisfaction is
not merely a consequence of patients’ clinical condition or
processes of care. The lack of association between patient
satisfaction with care and level of depressive affect is similar
to findings in previous studies of urban US HD patients.9,15
In previous work,9 patients’ satisfaction with staff was related
to Salb, a finding not confirmed in this study of European PD
patients.
Social support has been linked to patient survival in HD
patients.6,16,17 QOL indicators are associated with differential
survival in ESRD HD patients.6,7,11,18,19 Therefore, as patient
satisfaction is associated with improved perception of QOL
and social support, interventions directed at improving
patient satisfaction may have meaningful effects on hard
outcomes in PD patients.
This cohort of patients, with comparable age and Salb, had
lower perception of burden of illness, and greater perception
of satisfaction with life, social support, and patient satis-
faction compared with groups of urban US HD patients.6,9,15
The reasons for the differences outlined above between US
and European patient groups are unclear, but could include
differences in culture and ethnicity between patient groups,
or differences between PD and HD and their modes of care
may explain differences in psychosocial status between the
cohorts.
The CSQ was developed to assess PD patient satisfaction
as customers of FME, a major provider of dialysis products
and services. This survey indicates that the CSQ is an appro-
priate tool to measure PD patient customer satisfaction. The
internal consistency and validity of the questionnaire have
been established. Test–retest reliability confirms the stability
of the questionnaire scores over time. For any international
caregiver, it is useful to investigate the level of satisfaction
of their customers worldwide. To improve dialysis services,
clinical care, and patient outcomes, technical competence
should be combined with customer care skills. Therefore, an
instrument to effectively measure customer satisfaction is
essential. As this survey shows, the CSQ can efficiently assess
the level of PD patient satisfaction, in multiple domains. The
validation showed that it is possible to obtain satisfac-
tion indices without bias with the CSQ. As the CSQ was
developed as a modular questionnaire, it can be used flexibly.
A potential study limitation is the non-uniform use of
assessment criteria regarding decision-making capacity. In
addition, the findings should be replicated in international
populations and diverse groups. We acknowledge that
correlations outline bi-directional relationships, and causality
cannot be inferred from such analyses. Finally, experimental
demand may always be an issue when questionnaire data are
collected by research assistants.
This study demonstrates the CSQ is a useful, valid, and
reliable instrument to measure PD patient satisfaction with
medical care and services. This study has resulted in a
standardized and validated CSQ that can be used by health-
care or dialysis company personnel to determine the
satisfaction level of PD patients. PD patient satisfaction is
linked to perceptions of their QOL, but not to medical or
demographic factors. Interventions to improve PD patient
satisfaction are warranted, and may improve the quantity and
quality of our patients’ lives. Further study is necessary to
link satisfaction with care with meaningful outcomes in
ESRD patients.
MATERIALS AND METHODS
Patient population
This study was performed in 14 Hungarian FME centers caring for
home PD patients. All patients older than 18 years and treated with
chronic continuous ambulatory PD or automated PD for at least 3
months at the end of 2002 were eligible. Patients were excluded if
they lacked decision-making capacity or if there was doubt
regarding their ability to understand the questionnaire. Clinical
assessment was used to determine such exclusions. Each patient who
fulfilled eligibility criteria was invited to participate by the center
physician or nurse. Patients were enrolled after obtaining informed
consent regarding study purposes and procedures. A patient
subgroup was randomly selected for a second interview several
months later to evaluate test–retest reliability. Patients were only
interviewed after giving consent for the second interview.
Data collection and definitions
The study was performed using interview formats. All questions
were administered to patients verbally by trained personnel (social
workers or research assistants). If patients preferred, they could have
printed versions of the questions during the interview. Interviewers
were trained to have the skills to communicate with chronically ill
patients and to understand dialysis patients’ situations. To minimize
bias, interviewers were not affiliated with the centers in which the
interviews were conducted, and never met the patients before
interviews. Interviews took place during regular patient center visits.
Confidentiality regarding responses, and separation of data collec-
tion from influence on patient care were emphasized during the
consent process. If patients preferred, a separate visit was scheduled
exclusively for interviews. Interviews were expected to last at least
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1 h, but not to exceed 2 h. Breaks were given if patients desired.
To ensure confidentiality, coded identification numbers were used.
CSQ
The CSQ was developed specifically for PD patients by a group
consisting of a nephrologist, a nurse, a psychologist, marketing,
customer service and sales representatives, and a statistician. The
CSQ was developed to highlight salient issues for PD patients,
corresponding with commonly used customer satisfaction cate-
gories: Availability, Professionalism, Timeliness, Completeness, and
Overall Satisfaction with Support. The questionnaire covered
attributes of services such as: Availability (24 h service); Approach-
ability (‘On the second call I received an answer’); Courtesy (‘The
person who answered the phone was very kind’); Timeliness (‘They
quickly found a solution to my problem’); Confidence (‘I trust that
they will take care of my need or complaint’); Competence (‘The
person answering my question was knowledgeable’); and Commu-
nication (‘I could understand everything that they said’). Patients
were not involved in the creation of the initial instrument, but
patient feedback was obtained and included in the final ques-
tionnaire. After the first administration, some modifications were
suggested and some items were deleted from the CSQ. Exclusion
criteria were items: (1) strongly correlated with other CSQ items;
(2) with very high mean values; (3) with negative correlations with
the other items, as they do not measure the same construct;
(4) whose deletion markedly increased the Cronbach coefficient
alpha of the remaining questionnaire, and (5) for revision of content
validity. The CSQ was originally created in English and translated
into Hungarian by a native speaker, and then reviewed by native-
speaking nephrologists.
The resulting CSQ was comprised of 31 items divided into four
sections. Satisfaction level was evaluated using a seven-point Likert
scale. Higher scores represent higher satisfaction. The four sections
inquired about:
(1) Customer service score (CSS): Twelve items regarding patient
satisfaction with customer service. ‘Is the ordering process easy
or is the stock received without damage?’
(2) Delivery Service (DS): Five items regarding patient satisfaction
with delivery service. ‘The delivery truck driver rotates my
stock correctly.’
(3) PD Training: Five items regarding PD training. ‘I feel secure in
my daily PD routine.’
(4) Handling Requests: Nine items regarding complaint processes.
‘I always receive responses to my complaints.’
A total PDPSS was defined as the sum of the four subscores
(maximum, 217). After the interview, patients were asked for
comments and suggestions.
For validation, the CSQ was administered with five well-
established psychosocial measures previously used in ESRD patients,
as patient satisfaction with services could be associated with the
severity and perception of their illness, life circumstances, and social
support. Questionnaires included the TPSS,9 the IEQ,20,21 the BDI,22
the SWLS,23,24 and the MPSS.25,26
Patient Satisfaction: Total Patient Satisfaction Score. The
Patient Satisfaction Questionnaire27 measures patient perception of
physician care. A ‘Communication’ scale measures if patients
perceived they were provided sufficient information regarding the
illness. An ‘Affect’ scale measures patients’ perception of health-care
workers’ affective behavior, or the extent to which patients felt they
‘cared’ about them. These two scales correlate highly, but measure
different processes.27 Cronbach’s alpha was 0.92, and test–retest
reliability was 0.63. A total score sums the two individual scores.
Kovac et al.9 modified the questionnaire for use in ESRD HD
patients, including a response regarding the nursing, dietitian, social
work, and technical staff of the dialysis unit, doubling the number of
scales. The Physician Satisfaction score reflects the sum of patients’
perceptions of the Communication and Affect scores, related to
perceptions of the nephrologist. The Staff Satisfaction score reflects
the sum of patients’ perceptions of the Communication and Affect
scores, related to perception of the staff. Cronbach’s alpha for these
revised items ranged between 0.82 and 0.94. A total score, the TPSS,
sums the physician and staff scores. TPSS can range from 0 to 170.
Zero represents the least amount of satisfaction and 170 maximum
satisfactions.
Patients’ Perception of Illness. The IEQ, a generic measure of
how an illness interferes with or affects personal and social behavior,
consisting of 20 statements requiring responses on a seven-point
Likert scale, covering biological, social, and psychological issues
was used to measure perception of burden of illness. The IEQ has
high test–retest reliability (two-day test, retest of 0.95) and high
internal reliability.20,28 It has been used previously in ESRD
patients.6,8,11,21,29–31 IEQ scores in chronic kidney disease patients
correlate with other QOL measures,11,30 and predict mortality in
HD patients.6
Depression. The BDI was used to measure depressive
affect.22,32 The BDI assesses the presence of depression and its
level, examining 21 somatic symptoms and cognitive attitudes, rated
from 0 to 3. It is a well-validated depression measure in ESRD
patients, correlating with diagnostic criteria,22,32 used frequently in
ESRD.6,8,11,29–33 High scores predict ESRD patient mortality.8,31
Quality of life. The SWLS23,24 measures perception of general
QOL, consisting of five items with a 1 to 7 (low to high) satisfaction
rating. Items ask about ideal life and satisfaction with present and
past life situations. The SWLS demonstrated good internal
reliability, 2-month test–retest reliability and correlations with a
large number of subjective well-being scales,23 and has been used
previously in ESRD patients.6,11,30
Social support. Social support is information regarding how
an individual is a member of a complex network of affection,
mutual aid, and obligation.34 The MPSS25,26 is a 12-item inventory
of overall social support assessed on a seven-point Likert scale,
measuring total overall perceived social support from family,
friends, or persons who may serve in special support roles, but
may not be family members or friends. The MPSS has good internal
and test–retest reliability25 and has been used in chronic kidney
disease and ESRD patients.6,11,35
The Karnofsky Performance Status Scale36 measures patient
functional status, categorizing level of physical ability to perform
activities, used extensively11,19,30 in ESRD patients. Scores range
from 100 to 0, indicating full ability to carry out normal activity and
death, respectively. Scores below 70 represent requirement of some
level of additional assistance. Scores below 50 represent a functional
capacity that requires hospitalization, nursing home care, or
institutionalization.
Statistical considerations
Validity. A study objective was to demonstrate the CSQ
measures patient satisfaction with services, since only then are
inferences made from the scores meaningful. Construct validity
examines the agreement with standard tools.37 Therefore, the new
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questionnaire was compared with the results of the SWLS and the
TPSS, two questionnaires previously used in renal disease patients,
administered simultaneously.37 Pearson’s correlation coefficients
were used for comparisons.37,38 Construct validation is an analysis
of the meaning of test scores of psychologic concepts or ‘con-
structs’.38 The process of construct validation is similar to that by
which scientific theories are developed.38
Internal consistency. To investigate the internal consistency
(the degree to which items in the questionnaire measure the same
entity) of the CSQ, the Cronbach coefficient alpha was used.37,38 If
all items are perfectly reliable and measure the same latent variable,
a true score for patient satisfaction with services, they should be
highly correlated with each other and a high Cronbach coefficient
alpha will be obtained. The higher the alpha, the more reliable is the
questionnaire. This coefficient should be larger than 0.70.39
Evaluation of internal consistency also involves the correlation of
subtest scores with the total test score.38
Test–retest reliability. Test–retest reliability is an important
factor in assessing construct validity37 by demonstrating stability of
the construct over time.37 We measured test–retest reliability by the
Pearson correlation coefficient between questionnaire scores, and
the mean differences between scores at the two administrations, to
assess the stability of questionnaire scores over time.38 CSQ items
used in the first interview were maintained, whereas several new
items suggested after the administration of the first survey were
added. The Cronbach coefficient alpha was recalculated to assess the
internal consistency of the CSQ with the added items. Only the CSQ
was resubmitted to the patients. Sixty of the original 133 patients
were randomly selected for a second interview.
Factor analysis. To explore the potential underlying dimen-
sions associated with the 31-item CSQ, participant responses were
subjected to factor analysis, which identifies groups of items such
that there are strong correlations among all the items within the
group.38 Each factor has an associated eigenvalue, a measure of how
much of the variation in the data is accounted for by it.38 Factor
analysis with varimax rotation method was used.40 For the
determination of number of factors, the Kaiser rule of eigenvalues
greater than 1 was used.40
Statistical analysis
All statistical analyses were performed using SAS version 9.1 (SAS
Institute, Cary, NC, USA). Two sample t-tests and w2 analyses were
used to compare differences between group means and proportions
of variables with normal distributions. Mann–Whitney tests were
used to evaluate differences between variables with non-normal
distributions. Po0.05 was considered significant for all tests. Results
are expressed as mean7s.d.
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